Cancers
Experiences and Hopes Among Patients with Colorectal Carcinoma and Peritoneal Metastases Who Are Participating in an Early-Phase Clinical Trial.
Lena Fauske, Øyvind S Bruland, Anne Holtermann, Stein G Larsen
Published: 202610.3390/cancers18020244
Abstract
Background: Radspherin® is a novel α-emitting radiopharmaceutical administered intraperitoneally following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for peritoneal metastases. It delivers short-range rad…
Preview only. Read the full abstract at the source